Feed aggregator

COVID-19 vaccines pre-prepared in syringes can be safely transported

World Pharma News - Thu, 06/17/2021 - 12:00
One of the main reasons for the hold-ups in the mass vaccination campaigns against COVID-19 are the precautions that must be taken regarding the handling of the vaccines and their administration. They have to be transported under very specific conditions and the syringes used for their administration must be prepared at the same vaccination site.

CureVac provides update on Phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoV

World Pharma News - Thu, 06/17/2021 - 10:00
CureVac N.V. (Nasdaq: CVAC), a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced results of the second interim analysis of its international pivotal Phase 2b/3 study in approximatively 40,000 subjects (the HERALD study) of CureVac's first-generation COVID-19 vaccine candidate, CVnCoV.

Rare Blood Disease Drug Win Marks Fourth Approval for Blueprint Medicines

Biospace news - Thu, 06/17/2021 - 02:00
The U.S. FDA approved Ayvakit for the treatment of adult patients with advanced sytematic mastocytosis (SM), advanced SM, and mast cell leukemia.

Push to Public Continues as Biotech Dominates the IPO List This Week

Biospace news - Thu, 06/17/2021 - 02:00
Biotech companies are dominating Nasdaq’s IPO scheduled this week. Here’s who is making their big public debut.

CureVac Out of the COVID Race? Vaccine Only 47% Effective

Biospace news - Thu, 06/17/2021 - 02:00
The new findings likely throw a wrench in the company's plans to deliver millions of much-needed vaccine doses to the European Union soon.

Danaher Expands Life Sciences Segment with $9.6 Billion Buy

Biospace news - Thu, 06/17/2021 - 02:00
Global science and technology innovator Danaher Corporation is adding another company to its ever-growing global operation.

Another Experimental Alzheimer’s Treatment Fails in Phase II Study

Biospace news - Thu, 06/17/2021 - 02:00
Biogen’s quest to develop additional medicines for Alzheimer’s disease beyond its newly-approved aducanumab has hit a clinical snag after gosuranemab failed.

How Cancer Fools the Immune System Into Developing the Disease

Biospace news - Thu, 06/17/2021 - 02:00
Research shows that cancer can fool immune cells, which normally repair the body, into actually helping develop the disease.

Novartis Scores Breakthrough Therapy Designation to Speed Prostate Cancer Drug Approval

Biospace news - Thu, 06/17/2021 - 02:00
The FDA granted it to Lu-PSMA-617, an investigational radioligand therapy to treat metastatic castration-resistant prostate cancer.

Xilio Rides First Half Momentum to IND Acceptance for Checkpoint Inhibitor

Biospace news - Thu, 06/17/2021 - 02:00
XTX101 is a tumor-selective anti-CTLA-4 monoclonal antibody designed to improve upon the safety of current therapies in the same class.

Tumors Next Target for T Cell Therapies with U Minnesota Research

Biospace news - Thu, 06/17/2021 - 02:00
New research shows T cells can be engineered to migrate more effectively inside tumor microenvironments, raising hopes of reproducing the remarkable outcomes seen for certain hematological cancer patient subsets in broader populations and indications.

Global Roundup: DBI and Bayer Partner on Sleep Apnea Solution and More

Biospace news - Thu, 06/17/2021 - 02:00
Biopharma and life sciences companies from across the globe provide updates on their business operations and pipelines.

Recent Studies, Reports Call for Further Probe Into COVID-19 Origins

Biospace news - Thu, 06/17/2021 - 02:00
Scientists call for more investigation into the origin of the virus, particularly in China, but China now wants to include the U.S. in the probe.

13 Time Management Strategies for Effective Professionals

Biospace news - Thu, 06/17/2021 - 02:00
Here are some strategies to keep in mind to manage your time well and get work done efficiently.

U.S. government purchases additional 200 million doses of Moderna's COVID-19 vaccine

World Pharma News - Wed, 06/16/2021 - 10:00
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the U.S. government has purchased an additional 200 million doses of Moderna's COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna's pipeline.

Dana Farber and Harbour BioMed Team Up to Develop Novel Cancer Biotherapies

Biospace news - Wed, 06/16/2021 - 02:00
The research collaboration will see the development of bispecific antibodies and CAR-T cell products.

Novo Nordisk Partners With Seattle Biopharm to Research, Develop Obesity Therapies

Biospace news - Wed, 06/16/2021 - 02:00
Seattle-based clinical-stage biopharmaceutical company Lumen Bioscience is teaming up with Novo Nordisk to explore research and development opportunities within obesity, among other metabolic disorders.

Mallinckrodt's Regenerative Burn Therapy Gets FDA Nod

Biospace news - Wed, 06/16/2021 - 02:00
The product is designed to help heal patients who have received thermal burns that would ultimately require a skin graft.

Mnemo Breaks French Series A Record, Targets Greater Tumor Specificity

Biospace news - Wed, 06/16/2021 - 02:00
The Paris-based biotech will use the funds to create targeted immuno-oncology treatments for a broader range of patients with its next-generation CAR-T and epigenetics platform.

Watchdog Group Chastises Aducanumab Approval, Calls for More Resignations

Biospace news - Wed, 06/16/2021 - 02:00
In an eight page letter to U.S. DOH and Human Services Secretary Xavier Becerra, Public Citizen said Woodcock and other FDA officials should resign.